Page last updated: 2024-08-21

thiazoles and fh535

thiazoles has been researched along with fh535 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, X; Li, J; Li, T; Liu, F; Sun, X; Wang, F; Wang, X; Wei, H; Xiu, P; Xu, Z; Zhong, J	1

Other Studies

1 other study(ies) available for thiazoles and fh535

Article	Year
Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway. Oncology reports, 2016, Volume: 35, Issue:6 Topics: Antigens, CD; beta Catenin; Cadherins; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Activation; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Meloxicam; Neoplasm Invasiveness; RNA Interference; RNA, Small Interfering; Signal Transduction; Sulfonamides; Thiazines; Thiazoles	2016

Article

Year

Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.

Oncology reports, 2016, Volume: 35, Issue:6

Topics: Antigens, CD; beta Catenin; Cadherins; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Activation; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Meloxicam; Neoplasm Invasiveness; RNA Interference; RNA, Small Interfering; Signal Transduction; Sulfonamides; Thiazines; Thiazoles

2016